有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | (2S)-3-[[5-[[(2R)-oxolan-2-yl]methylamino]-1,3,4-thiadiazol-2-yl]sulfanyl]propane-1,2-diol | —— | C10H17N3O3S2 |
|
—— | (2S)-N-[[1-(4-fluorophenyl)cyclobutyl]methyl]-2-pyrimidin-2-ylsulfanylpropanamide | —— | C18H20FN3OS |
|
—— | 2-(3,4-dimethylphenyl)sulfanyl-N-[(2S)-1-methoxypropan-2-yl]acetamide | —— | C14H21NO2S |
|
—— | 3-methyl-5-[(1R)-1-(4-methylphenyl)sulfanylethyl]-1,2,4-oxadiazole | —— | C12H14N2OS |
|
—— | 3-methyl-5-[(1S)-1-(4-methylphenyl)sulfanylethyl]-1,2,4-oxadiazole | —— | C12H14N2OS |
|
—— | 6-Tert-butyl-3-methyl-2-[(2-methylphenyl)methylsulfanyl]pyrimidin-4-one | —— | C17H22N2OS |
|
—— | (2R)-N-[[1-(4-fluorophenyl)cyclobutyl]methyl]-2-pyrimidin-2-ylsulfanylpropanamide | —— | C18H20FN3OS |
|
—— | 2-(3,4-dimethylphenyl)sulfanyl-N-[(2R)-1-methoxypropan-2-yl]acetamide | —— | C14H21NO2S |
|
—— | 2-(1-Methyltetrazol-5-yl)sulfanylethyl-[(5-phenylfuran-2-yl)methyl]azanium | —— | C15H18N5OS+ |
|
—— | 5-[(6-Methyl-2-piperidin-1-ylpyrimidin-4-yl)sulfanylmethyl]-3-(morpholin-4-ium-4-ylmethyl)-1,3,4-oxadiazole-2-thione | —— | C18H27N6O2S2+ |
|
—— | N-[[(2S)-oxolan-2-yl]methyl]-2-[[5-(thiophen-2-ylmethyl)-1H-1,2,4-triazol-3-yl]sulfanyl]acetamide | —— | C14H18N4O2S2 |
|
—— | [5-(4-Chlorophenyl)furan-2-yl]methyl-[2-(1-methyltetrazol-5-yl)sulfanylethyl]azanium | —— | C15H17ClN5OS+ |
|
—— | [5-(3-Chlorophenyl)furan-2-yl]methyl-[2-(1-methyltetrazol-5-yl)sulfanylethyl]azanium | —— | C15H17ClN5OS+ |
|
—— | methyl (2R)-2-[(6-phenyl-1,2,4-triazin-3-yl)sulfanyl]propanoate | —— | C13H13N3O2S |
|
—— | [5-(4-Fluorophenyl)furan-2-yl]methyl-[2-(1-methyltetrazol-5-yl)sulfanylethyl]azanium | —— | C15H17FN5OS+ |
|
—— | 6-Phenyl-3-(2-piperidin-1-ium-1-ylethylsulfanyl)-1,2,4-triazine | —— | C16H21N4S+ |
|
—— | methyl (2S)-2-[(6-phenyl-1,2,4-triazin-3-yl)sulfanyl]propanoate | —— | C13H13N3O2S |
|
—— | (1S)-1-[4-butyl-5-(pyridin-2-ylmethylsulfanyl)-1,2,4-triazol-3-yl]-N,N-dimethylpropan-1-amine | —— | C17H27N5S |
|
—— | N-benzyl-N-[(2S)-butan-2-yl]-3-(1-methyltetrazol-5-yl)sulfanylpropanamide | —— | C16H23N5OS |
|
—— | (2S)-N-[1-(2-methylpropyl)piperidin-4-yl]-2,3-dihydro-1,4-benzoxathiine-2-carboxamide | —— | C18H26N2O2S |
|
—— | (2R)-N-[(1S)-1-[(2S)-oxolan-2-yl]ethyl]-2-pyrimidin-2-ylsulfanylpropanamide | —— | C13H19N3O2S |
|
—— | (1R)-1-[4-butyl-5-(pyridin-2-ylmethylsulfanyl)-1,2,4-triazol-3-yl]-N,N-dimethylpropan-1-amine | —— | C17H27N5S |
|
—— | (2R)-N-[1-(2-methylpropyl)piperidin-4-yl]-2,3-dihydro-1,4-benzoxathiine-2-carboxamide | —— | C18H26N2O2S |
|
—— | N-[[(2R)-oxolan-2-yl]methyl]-2-[[5-(thiophen-2-ylmethyl)-1H-1,2,4-triazol-3-yl]sulfanyl]acetamide | —— | C14H18N4O2S2 |
|
—— | (2R)-N-[(1R)-1-[(2S)-oxolan-2-yl]ethyl]-2-pyrimidin-2-ylsulfanylpropanamide | —— | C13H19N3O2S |
|
—— | (2R)-N-[(1S)-1-[(2R)-oxolan-2-yl]ethyl]-2-pyrimidin-2-ylsulfanylpropanamide | —— | C13H19N3O2S |
|
—— | (2S)-N-[3-chloro-4-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]phenyl]-2-methylbutanamide | —— | C14H17ClN4OS |
|
—— | 2-pyridin-4-yl-5-[(1S)-1-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)ethyl]sulfanyl-1,3,4-oxadiazole | —— | C16H12N6O2S |
|
—— | 2-pyridin-4-yl-5-[(1R)-1-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)ethyl]sulfanyl-1,3,4-oxadiazole | —— | C16H12N6O2S |
|
—— | (2R)-N-[(1R)-1-[(2R)-oxolan-2-yl]ethyl]-2-pyrimidin-2-ylsulfanylpropanamide | —— | C13H19N3O2S |
|
—— | (2R)-N-[3-chloro-4-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]phenyl]-2-methylbutanamide | —— | C14H17ClN4OS |
|
—— | 4-methyl-1-[4-[[(2R)-oxolan-2-yl]methyl]-5-prop-2-enylsulfanyl-1,2,4-triazol-3-yl]piperidine | —— | C16H26N4OS |
|
—— | (3S)-N-[2-methyl-4-[(4-methyl-1,3-thiazol-2-yl)sulfanyl]phenyl]oxolane-3-carboxamide | —— | C16H18N2O2S2 |
|
—— | N-[(3R)-1,1-dioxothiolan-3-yl]-2-(3-methylphenyl)sulfanylacetamide | —— | C13H17NO3S2 |
|
—— | 4-(2-Chlorophenyl)sulfanyl-2-ethanimidoyl-3-oxobutanenitrile | —— | C12H11ClN2OS |
|
—— | 1-[(2R)-2-(3-fluorophenyl)-2-hydroxyethyl]-3-[(4-methylsulfanylphenyl)methyl]urea | —— | C17H19FN2O2S |
|
—— | (2S)-2-(4-bromophenyl)sulfanyl-N-(1-butylpiperidin-4-yl)propanamide | —— | C18H27BrN2OS |
|
—— | (2R)-2-(4-bromophenyl)sulfanyl-N-(1-butylpiperidin-4-yl)propanamide | —— | C18H27BrN2OS |
|
—— | 1-[4-[[(2R)-oxolan-2-yl]methyl]-5-propan-2-ylsulfanyl-1,2,4-triazol-3-yl]piperidine | —— | C15H26N4OS |
|
—— | 4-methyl-N'-[(5-methylsulfanyl-1,3,4-thiadiazol-2-yl)methoxy]benzenecarboximidamide | —— | C12H14N4OS2 |
|
—— | 1-[4-[[(2S)-oxolan-2-yl]methyl]-5-propan-2-ylsulfanyl-1,2,4-triazol-3-yl]piperidine | —— | C15H26N4OS |
|
—— | N-[(2-chlorophenyl)methyl]-2-[4-(3,5-dimethylphenyl)-3-oxopyrazin-2-yl]sulfanylacetamide | —— | C21H20ClN3O2S |
|
—— | ethyl (2S)-2-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]-2-phenylacetate | —— | C13H15N3O2S |
|
—— | ethyl (2R)-2-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]-2-phenylacetate | —— | C13H15N3O2S |
|
—— | 2-((4-(3,5-dimethylphenyl)-3-oxo-3,4-dihydropyrazin-2-yl)thio)-N-phenethylacetamide | —— | C22H23N3O2S |
|
—— | (6R)-4-methyl-5-[3-(4-methylphenyl)-2H-1,2,4-oxadiazol-5-ylidene]-6-(4-methylsulfanylphenyl)-1,6-dihydropyrimidine-2-thione | —— | C21H20N4OS2 |
|
—— | 3-(4-fluorophenyl)sulfanyl-N-[[(2S)-1-methylpyrrolidin-2-yl]methyl]propanamide | —— | C15H21FN2OS |
|
—— | 3-(4-chlorophenyl)sulfanyl-N-[[(2R)-1-methylpyrrolidin-2-yl]methyl]propanamide | —— | C15H21ClN2OS |
|
—— | 3-(4-fluorophenyl)sulfanyl-N-[[(2R)-1-methylpyrrolidin-2-yl]methyl]propanamide | —— | C15H21FN2OS |
|
—— | 3-(4-chlorophenyl)sulfanyl-N-[[(2S)-1-methylpyrrolidin-2-yl]methyl]propanamide | —— | C15H21ClN2OS |
|